{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-114055","form_type":"8-K","ticker":null,"cik":"0000786947","company_name":"ACURA PHARMACEUTICALS, INC","filed_at":"2026-10-06T20:16:16+00:00","discovered_at":"2026-10-06T20:17:00.247371+00:00","generated_at":"2026-10-12T16:17:51.168014+00:00","sec_items":["1.01","2.01","2.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Acura Pharmaceuticals borrows $200,000 from Abuse Deterrent Pharma; note principal reaches $11,294,279","bullets":["Acura received $100,000 loans from Abuse Deterrent Pharma on Sept 18 and Oct 2, 2026, raising the secured note principal to $11,294,279.","Accrued interest was about $1,365,000 as of Sept 30, 2026; the note bears 5.25%, with overdue amounts at 7.5%.","Absent additional financing by mid-October 2026, Acura says it may scale back operations, furlough or lay off employees, terminate operations, or seek bankruptcy protection.","Events of default include failure to pay principal or interest continuing 5 days, bankruptcy events, and inability to pay debts as they come due.","Exhibit 99.1 lists Loans #51 through #66, including Loan #66 dated Oct 2, 2026 for $100,000."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-114055","json":"https://secwatch.observer/filing/0001104659-26-114055.json","markdown":"https://secwatch.observer/filing/0001104659-26-114055.md","text":"https://secwatch.observer/filing/0001104659-26-114055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/786947/000110465926114055/0001104659-26-114055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/786947/000110465926114055/tm2627130d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:17:51.168014+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}